Biomarkers of cell death in Alzheimer’s reverse course after symptom onset
Three promising biomarkers being studied to detect Alzheimer’s disease in its early stages appear to undergo a surprising shift as patients develop symptoms of dementia, researchers led by Anne Fagan, PhD, at the School of Medicine report.